vs
Amalgamated Financial Corp.（AMAL）与Cytek Biosciences, Inc.（CTKB）财务数据对比。点击上方公司名可切换其他公司
Amalgamated Financial Corp.的季度营收约是Cytek Biosciences, Inc.的1.4倍（$85.2M vs $62.1M），Amalgamated Financial Corp.同比增速更快（9.4% vs 8.1%），Amalgamated Financial Corp.自由现金流更多（$134.4M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 4.3%）
CI金融集团是一家总部位于加拿大安大略省多伦多的投资管理公司，面向高净值个人投资者提供投资管理与财富管理服务，同时也为投资组合经理及机构投资者提供经纪与交易服务。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
AMAL vs CTKB — 直观对比
营收规模更大
AMAL
是对方的1.4倍
$62.1M
营收增速更快
AMAL
高出1.3%
8.1%
自由现金流更多
AMAL
多$136.2M
$-1.8M
两年增速更快
CTKB
近两年复合增速
4.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $85.2M | $62.1M |
| 净利润 | — | $-44.1M |
| 毛利率 | — | 52.9% |
| 营业利润率 | 39.0% | -9.0% |
| 净利率 | — | -70.9% |
| 营收同比 | 9.4% | 8.1% |
| 净利润同比 | — | -557.1% |
| 每股收益（稀释后） | $0.88 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMALCTKB
| Q4 25 | $85.2M | $62.1M | ||
| Q3 25 | $85.6M | $52.3M | ||
| Q2 25 | $80.9M | $45.6M | ||
| Q1 25 | $77.0M | $41.5M | ||
| Q4 24 | $77.9M | $57.5M | ||
| Q3 24 | $81.0M | $51.5M | ||
| Q2 24 | $78.5M | $46.6M | ||
| Q1 24 | $78.3M | $44.9M |
净利润AMALCTKB
| Q4 25 | — | $-44.1M | ||
| Q3 25 | $26.8M | $-5.5M | ||
| Q2 25 | $26.0M | $-5.6M | ||
| Q1 25 | $25.0M | $-11.4M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $27.9M | $941.0K | ||
| Q2 24 | $26.8M | $-10.4M | ||
| Q1 24 | $27.2M | $-6.2M |
毛利率AMALCTKB
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
营业利润率AMALCTKB
| Q4 25 | 39.0% | -9.0% | ||
| Q3 25 | 42.9% | -17.6% | ||
| Q2 25 | 43.8% | -23.3% | ||
| Q1 25 | 45.1% | -36.1% | ||
| Q4 24 | 42.4% | 5.2% | ||
| Q3 24 | 47.2% | -8.2% | ||
| Q2 24 | 45.6% | -18.3% | ||
| Q1 24 | 49.2% | -23.9% |
净利率AMALCTKB
| Q4 25 | — | -70.9% | ||
| Q3 25 | 31.3% | -10.5% | ||
| Q2 25 | 32.1% | -12.2% | ||
| Q1 25 | 32.5% | -27.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | 34.5% | 1.8% | ||
| Q2 24 | 34.1% | -22.4% | ||
| Q1 24 | 34.8% | -13.8% |
每股收益（稀释后）AMALCTKB
| Q4 25 | $0.88 | — | ||
| Q3 25 | $0.88 | — | ||
| Q2 25 | $0.84 | — | ||
| Q1 25 | $0.81 | — | ||
| Q4 24 | $0.78 | — | ||
| Q3 24 | $0.90 | — | ||
| Q2 24 | $0.87 | — | ||
| Q1 24 | $0.89 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $291.2M | $90.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $794.5M | $341.7M |
| 总资产 | $8.9B | $461.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMALCTKB
| Q4 25 | $291.2M | $90.9M | ||
| Q3 25 | $115.5M | $93.3M | ||
| Q2 25 | $171.1M | $75.5M | ||
| Q1 25 | $65.7M | $95.3M | ||
| Q4 24 | $60.7M | $98.7M | ||
| Q3 24 | $149.2M | $162.3M | ||
| Q2 24 | $58.0M | $177.9M | ||
| Q1 24 | $155.2M | $168.8M |
股东权益AMALCTKB
| Q4 25 | $794.5M | $341.7M | ||
| Q3 25 | $775.6M | $378.6M | ||
| Q2 25 | $754.0M | $377.6M | ||
| Q1 25 | $736.0M | $379.6M | ||
| Q4 24 | $707.7M | $395.7M | ||
| Q3 24 | $698.2M | $385.5M | ||
| Q2 24 | $646.0M | $389.1M | ||
| Q1 24 | $616.8M | $392.6M |
总资产AMALCTKB
| Q4 25 | $8.9B | $461.5M | ||
| Q3 25 | $8.7B | $494.9M | ||
| Q2 25 | $8.6B | $493.3M | ||
| Q1 25 | $8.3B | $482.6M | ||
| Q4 24 | $8.3B | $499.5M | ||
| Q3 24 | $8.4B | $491.2M | ||
| Q2 24 | $8.3B | $483.7M | ||
| Q1 24 | $8.1B | $492.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $135.8M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | $134.4M | $-1.8M |
| 自由现金流率自由现金流/营收 | 157.8% | -2.9% |
| 资本支出强度资本支出/营收 | 1.6% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $229.4M | $-8.8M |
8季度趋势，按日历期对齐
经营现金流AMALCTKB
| Q4 25 | $135.8M | $-771.0K | ||
| Q3 25 | $39.5M | $-3.9M | ||
| Q2 25 | $24.9M | $108.0K | ||
| Q1 25 | $34.2M | $-125.0K | ||
| Q4 24 | $124.1M | $2.0M | ||
| Q3 24 | $35.8M | $13.2M | ||
| Q2 24 | $28.0M | $6.2M | ||
| Q1 24 | $31.3M | $4.0M |
自由现金流AMALCTKB
| Q4 25 | $134.4M | $-1.8M | ||
| Q3 25 | $38.3M | $-4.6M | ||
| Q2 25 | $24.2M | $-1.5M | ||
| Q1 25 | $32.5M | $-974.0K | ||
| Q4 24 | $122.3M | $1.1M | ||
| Q3 24 | $35.2M | $12.2M | ||
| Q2 24 | $27.8M | $5.2M | ||
| Q1 24 | $31.1M | $3.4M |
自由现金流率AMALCTKB
| Q4 25 | 157.8% | -2.9% | ||
| Q3 25 | 44.7% | -8.7% | ||
| Q2 25 | 29.9% | -3.2% | ||
| Q1 25 | 42.2% | -2.3% | ||
| Q4 24 | 157.0% | 1.9% | ||
| Q3 24 | 43.4% | 23.7% | ||
| Q2 24 | 35.4% | 11.0% | ||
| Q1 24 | 39.7% | 7.6% |
资本支出强度AMALCTKB
| Q4 25 | 1.6% | 1.6% | ||
| Q3 25 | 1.4% | 1.3% | ||
| Q2 25 | 0.9% | 3.5% | ||
| Q1 25 | 2.3% | 2.0% | ||
| Q4 24 | 2.3% | 1.6% | ||
| Q3 24 | 0.7% | 2.0% | ||
| Q2 24 | 0.3% | 2.3% | ||
| Q1 24 | 0.3% | 1.3% |
现金转化率AMALCTKB
| Q4 25 | — | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 0.96× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | 1.28× | 14.05× | ||
| Q2 24 | 1.05× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMAL
暂无分部数据
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
